Related Experiment Video
Updated: Mar 15, 2026
10:44
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
10.3K
In Vitro Drug Metabolism Using Liver Microsomes
Kathleen M Knights1, David M Stresser2, John O Miners3
1Department of Clinical Pharmacology, School of Medicine, Flinders University, Adelaide, South Australia, Australia.
Current Protocols in Pharmacology
|September 17, 2016
Summary
Understanding drug metabolism is key for predicting pharmacokinetics (PK) and potential drug interactions. This study details methods for assessing metabolic stability and identifying drug-metabolizing enzymes using microsomes.
Area of Science:
- Pharmacology
- Drug Metabolism
- Biochemistry
Background:
- Accurate prediction of pharmacokinetic (PK) parameters, including dosing and frequency, relies on understanding how drug candidates are metabolized.
- Characterizing the specific enzymes responsible for drug metabolism (reaction phenotyping) is crucial for anticipating metabolic drug-drug interactions and their impact on drug clearance.
Purpose of the Study:
- To describe methods for isolating microsomes, which are a rich source of major drug-metabolizing enzymes.
- To outline procedures for determining the metabolic stability of new chemical entities (NCEs).
- To detail techniques for metabolite identification and kinetic analysis.
Main Methods:
- Microsome isolation from biological sources.
- Assay development for measuring metabolic stability.
- Reaction phenotyping using isolated microsomes to identify key drug-metabolizing enzymes like Cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
- Determination of metabolite formation and kinetic parameters.
Main Results:
- Established protocols for reliable microsome preparation.
- Validated methods for quantifying drug disappearance and metabolite generation over time.
- Demonstrated the utility of microsomes for both metabolic stability and reaction phenotyping.
Conclusions:
- Microsomes are a vital tool for assessing drug metabolic stability and identifying metabolic pathways.
- These methods are essential for early-stage drug discovery and development, enabling prediction of in vivo PK and potential interactions.
- The described techniques support informed decision-making regarding drug candidate progression and optimization.
Related Concept Videos
01:28Drug Biotransformation: Overview
5.0K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
5.0K
01:16Drug Biotransformation: Overview
4.1K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
4.1K
01:17Drug Metabolism: Phase I Reactions
5.5K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
5.5K
01:27Pharmacogenetics of Drug Metabolism: Overview
88
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
88
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
310
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
310
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
90
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
90